• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Canada·Healthcare·TER.CN
Share

TerrAscend Corp. Stocks

CA$ 0Last Updated 18.08.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

CA$ 586.45M

CA$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

TerrAscend Corp. operates as a comprehensive cannabis enterprise, engaging in the cultivation, processing, and distribution of cannabis products for both medical and regulated adult recreational markets across Canada and the United States. In addition to its core cannabis operations, the firm also develops and supplies hemp-derived wellness items to retail outlets and crafts specialty cannabis-infused edibles. It further expands its market presence by managing a network of retail dispensaries under The Apothecarium brand name in California, Pennsylvania, and New Jersey. The company's portfolio encompasses various integrated businesses and brands, including Gage Growth, Pinnacle, Ilera Healthcare, Valhalla Confections, State Flower, and Arise Bioscience Inc., among others. Established in 2017, TerrAscend maintains its corporate headquarters in Mississauga, Canada.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is 'cheap' on EV/EBITDA, overvalued

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.10.2026 13:25

Nasdaq futures fell 1.3%: Alphabet's earnings report could halt the tech rally

29.10.2026 12:09

The AI boom increased Samsung's profits nearly ninefold. Why did its stock plummet?

29.10.2026 11:46

Morning Roundup: Alphabet Shares Plunge After Earnings Report; Marvell Prepares for a Mega Deal

29.10.2026 09:01

Boeing's stock has fallen 23% since the start of the year. Is it worth buying on the dip?

29.10.2026 06:59

"Mega Deal": Marvell Is in Talks to Acquire Lumentum, a Developer of Data Center Optics

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026